Preoperative Anemia Prior to Gynecologic Surgery is Associated With Increased Healthcare Costs

Objective: To compare healthcare utilization costs between anemic and nonanemic patients undergoing elective hysterectomy and myomectomy for benign indications from the date of surgery to 30 days postoperatively. Design: Retrospective population-based cohort study. Setting: Single-payer publicly funded healthcare system in Ontario, Canada between 2013 and 2020. Participants: Adult women (>= 18 >= 18 years of age) who underwent elective hysterectomy or myomectomy (laparoscopic/laparotomy) for benign indications. Interventions: Our exposure of interest was preoperative anemia, defined as the most recent hemoglobin value < 12 g/dL on the complete blood count measured before the date of surgery. Our primary outcome was healthcare costs (total and disaggregated) from the perspective of the single-payer publicly funded healthcare system. Results: Of the 59 270 patients in the cohort, 11 802 (19.9%) had preoperative anemia. After propensity matching, standardized differences in all baseline characteristics (N N = 10 103 per group) were < 0.10. In the matched cohort, the mean total healthcare cost per anemic patient was higher compared to cost per nonanemic patient ($6134.88 $2782.38 vs $6009.97 $2423.27, p < .001). Anemic patients, compared to nonanemic patients, had a higher mean difference in total healthcare cost of $124.91 per patient (95% CI $53.54-$196.29) - $196.29) translating to an increased cost attributable to anemia of 2.08% (95% CI 0.89%-3.28%, - 3.28%, p < .001). In a subgroup analysis of patients undergoing hysterectomy (N N = 9041), the cost was also significantly higher for anemic patients (mean difference per patient of $117.67, 95% CI $41.58-$193.75). - $193.75). For those undergoing myomectomy (N N = 1062) the difference in cost was not statistically significant (mean difference $186.61, 95% CI - $17.42 to $390.65). Conclusion: Preoperative anemia was associated with significantly increased healthcare resource utilization and costs for patients undergoing elective gynecologic surgery. Although the cost difference per case was modest, when extrapolated to the population level, this difference could result in substantially significant cost to the healthcare system, attributable to preoperative anemia. Journal of Minimally Invasive Gynecology (2024) 31, 778-786. - 786. (c) 2024 AAGL. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)